Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches

Research output: Contribution to journalArticle

194 Citations (Scopus)

Abstract

Inclusion body myositis is the most common acquired muscle disease in older individuals, and its prevalence varies among countries and ethnic groups. The aetiology and pathogenesis of sporadic inclusion body myositis are still poorly understood; however genetic factors, ageing, and environmental triggers might all have a role. Unlike other inflammatory myopathies, sporadic inclusion body myositis causes slowly progressing muscular weakness and atrophy, it has a distinctive pattern of muscle involvement, and is unresponsive to conventional forms of immunotherapy. This review covers the clinical presentation, diagnosis, treatment, and the latest information on genetic susceptibility and pathogenesis of sporadic inclusion body myositis.
Original languageEnglish
Pages (from-to)620-631
JournalThe Lancet Neurology
Volume6
Issue number7
DOIs
Publication statusPublished - 2007

Fingerprint Dive into the research topics of 'Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches'. Together they form a unique fingerprint.

Cite this